Join us at the Respiratory Drug Delivery Congress (RDD), a key international event dedicated to the best science, technology and services in the field of pulmonary and nasal drug delivery, where we will be showcasing our scientific expertise. The congress is fully virtual (as 2020) and will occur between May 4th to 7th2021.
Andreas Meliniotis, Director Device Development, will be discussing sustainability and connectivity in his presentation “Balancing User and Environmental Needs in Inhaler Design”, highlighting the tension between greater device functionality and increasing energy requirements, as well as proposing a number of strategies to help overcome.
Martin Oliver, Tina Hart, Bradley Morrical and Andreas Meliniotis will also be reviewing DPI and pMDI generic development in the workshop “Inhaled Bioequivalence: A Broader View of Product Development”.
Mireia Puig and Daniel Lock are presenting their poster “Inhaled Heparin Formulations to Treat Cystic Fibrosis”, discussing the performance of a dry powder capsule inhaler and the FOX® nebuliser. The Vectura team will be available to answer questions and to connect about all aspects of inhaled product development.
Finally, Geraldine Venthoye, Chief Scientific Officer and Executive Vice President – Product Development, will be moderating the live Q&A and panel discussion for the session, “Respiratory Science Responds to SARS-COV2 and Lung Diseases”.
We look forward to discussing these topics and more during the event.
Click here for further information and downloadable content at our exhibition.